Valuation : BioHarvest Sciences Inc.

Market Cap 43.52M 37.55M 35.37M 32.23M 60.24M 4.11B 60.69M 419M 163M 2.1B 163M 160M 6.9B P/E 2026 *
-3.64x
P/E 2027 * -5.73x
Enterprise Value 43.52M 37.55M 35.37M 32.23M 60.24M 4.11B 60.69M 419M 163M 2.1B 163M 160M 6.9B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 0.88x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 2026-04-28
Director of Finance/CFO - 2024-10-27
Chief Operating Officer 65 2023-04-18
Director TitleAgeSince
Chairman 68 2018-09-26
Director/Board Member 67 2018-09-26
Director/Board Member 84 2019-02-06
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 43.52M
-0.16%+1.20%-14.66%-7.26% 13.45B
-0.71%-1.69%-33.92%-56.88% 4.9B
-0.36%-3.01%-8.51%-5.52% 4.52B
-1.81%-2.11%-5.86%-31.64% 3.99B
-0.72%-0.61%-21.46%+1.39% 3.57B
-2.27%+0.32%-2.80%-4.50% 3.51B
-0.88%-0.81%-11.39%+4.57% 3.28B
-1.46%-3.14%-25.48%-14.97% 2.36B
-1.08%+0.15%-27.68%-16.31% 1.72B
Average -0.34%-1.77%-16.86%-14.57% 4.59B
Weighted average by Cap. -0.80%-1.08%-15.90%-14.21%

Financials

2026 *2027 *
Net sales 37.42M 32.28M 30.41M 27.71M 51.79M 3.53B 52.18M 360M 140M 1.81B 141M 137M 5.94B 49.59M 42.78M 40.3M 36.72M 68.63M 4.68B 69.15M 477M 185M 2.4B 186M 182M 7.87B
Net income -12.02M -10.37M -9.77M -8.9M -16.63M -1.14B -16.76M -116M -44.88M -580M -45.13M -44.15M -1.91B -7.65M -6.6M -6.22M -5.66M -10.58M -722M -10.66M -73.58M -28.56M -369M -28.72M -28.09M -1.21B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.920USD
Average target price
10.50USD
Spread / Average Target
+446.88%

Quarterly revenue - Rate of surprise